Losing Strategies

<p>As the head of the U.S. Department of Health and Human Services announced Monday that he was ordering a review of a planned 15% hike in the Medicare Part B premium for 2022, healthcare reform advocates stressed the need for Congress to pass a Build Back Better bill with a provision allowing the federal government to negotiate the price of prescription drugs. Corbevax is targeting low-income countries to stop new COVID variants from emerging. Scientists say rich countries are still refusing to fund it. Two absolutely insane op-ed pieces on the same day: Hillary Clinton 2024 Election Comeback and Biden-Cheney 2024. In...